4-1BB Signaling Boosts the Anti-Tumor Activity of CD28-Incorporated 2(nd) Generation Chimeric Antigen Receptor-Modified T Cells

While chimeric antigen receptor-modified T (CAR-T) cells have shown great success for the treatment of B cell leukemia, their efficacy appears to be compromised in B cell derived lymphoma and solid tumors. Optimization of the CAR design to improve persistence and cytotoxicity is a focus of the curre...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Qiang, Han, Ping, Qi, Xinyue, Li, Fanlin, Li, Min, Fan, Lilv, Zhang, Huihui, Zhang, Xiaoqing, Yang, Xuanming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691374/
https://www.ncbi.nlm.nih.gov/pubmed/33281809
http://dx.doi.org/10.3389/fimmu.2020.539654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691374/
https://www.ncbi.nlm.nih.gov/pubmed/33281809
http://dx.doi.org/10.3389/fimmu.2020.539654

Ejemplares similares